Several studies report coexistent or subsequent primary tumors (SPT) among patients with malignant melanoma (MM), with the rate of incidence ranging from 1.5-20% depending on the sample size and the length and completeness of follow-up. ## METHODS. The authors followed a cohort of patients with c
Second primary malignancies in females with primary fallopian tube cancer
✍ Scribed by Annika Riska; Eero Pukkala; Ghislaine Scélo; Lene Mellemkjaer; Kari Hemminki; Elisabete Weiderpass; Mary L. McBride; Vera Pompe-Kirn; Elizabeth Tracey; David H. Brewster; Erich V. Kliewer; Jon M. Tonita; Chia Kee-Seng; Jon G. Jonasson; Carmen Martos; Paolo Boffetta; Paul Brennan
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 77 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Primary fallopian tube cancer (PFTC) is a rare disease, and its aetiological factors are poorly understood. Studies on PFTC in the setting of 2nd primary malignant neoplasms can provide clues on aetiology and also define the possible side effects of different treatment modalities for PFTC. A cohort of 2,084 cases with first PFTC was extracted from the data from 13 cancer registries from Europe, Canada, Australia and Singapore and followed for second primary cancers within the period 1943–2000. Standardized incidence ratios (SIRs) were calculated and Poisson regression analyses were done to find out the RRs related to age at, period of and time since the PFTC diagnosis. There were 118 cancer cases observed after first PFTC (SIR 1.4, 95%CI 1.1–1.6). Elevated SIRs were seen for colorectal cancer (1.7, 95%CI 1.0–2.6), for breast cancer (1.5, 95%CI 1.1–2.2), for bladder cancer (2.8, 95%CI 1.0–6.0), for lung cancer (1.8, 95% CI 0.9–3.2) and for nonlymphoid leukaemia (3.7, 95%CI 1.0–9.4). Significant risk increases were detected for colorectal cancer during the 2nd to 5th year after the first PFTC diagnosis, for breast cancer in follow‐up 10+ and for nonlymphoid leukaemia during the 2nd to 10th year. The clustering of cancers of the lung and bladder in PFTC patients may suggest shared smoking aetiology. The excess of colorectal and breast cancers after PFTC may indicate a genetic aetiology. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
There are only limited population-based data available regarding the risk of developing a second cancer after a diagnosis of lung carcinoma. ## METHODS. Data collected from the Cancer Registry of the Swiss Canton of Vaud (comprised of approximately 600,000 inhabitants) were used to estimate the i
Background. Patients with cancer of the oral cavity and pharynx have been described to be particularly susceptible to the development of new cancers. Methods. Using data collected during 1973-1987 by nine population-based cancer registries in the United States, the authors evaluated risks of second
This report is based on responses to a mailed questionnaire from 927 patients with lung cancer (730 men, 197 women), or their next of kin, and information obtained from the Saskatchewan Cancer Foundation Tumour Registry. Women were diagnosed at an earlier mean age than males (X +-SE, 63.5 f 0.85 yea
## Abstract Survival from soft tissue tumors (STTs) has been improved because of the successful treatment. One of the late sequelae in STT survivors is the development of a second malignancy. The present study aimed at quantifying risks for second malignancies in patients with STTs, and risks for s